Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in ...
Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s ...
Abbott, the creator of continuous glucose monitors, launched the new Assist feature at CES 2026. Part of the Libre app, it ...
Abbott has launched Libre Assist, a feature within the Libre app designed to help people living with diabetes better understand how the foods they eat affect their glucose levels.
If you build engines, tune cars, or even just like mashing your foot on the throttle with conviction, you’ve probably heard ...
PODD gains momentum as Omnipod 5 adoption accelerates, margins scale, and earnings estimates rise despite macro and concentration risks.
Growing up, pro skier Xander Guldman didn’t spend much time in the terrain parks at his home resort of Sugar Bowl, California. The Lake Tahoe area mountain offered hand-built jumps, but when it came ...
Abbott (NYSE:ABT) today unveiled a new feature within its FreeStyle Libre app for continuous glucose monitoring (CGM).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback